bioRxivMicrobiologyPreprint
Quantitation of vector uptake reveals non-Poissonian transfection dynamics in Plasmodium falciparum
M. Carrasquilla, T. Sanderson, R. Montadon, J. Rayner, A. Pance, M. Lee
Abstract
The recurrent emergence of drug resistance in Plasmodium falciparum increases the urgency to genetically validate drug resistance mechanisms and identify new targets. Reverse genetics have facilitated genome-scale knockout screens in Plasmodium berghei and Toxoplasma gondii, in which pooled transfections of multiple vectors were critical to increasing scale and throughput. These approaches have not yet been implemented in P. falciparum, mainly because the extent to which pooled transfections can be performed in this species still remains unknown. Here we use next-generation sequencing to quantitate uptake of a pool of 94 barcoded vectors. The distribution of vectors in different transfections allowed us to estimate the number of barcodes and DNA molecules taken up by the parasite population. Dilution cloning showed that single transfected parasites routinely carry as many as seven episomal barcodes, revealing an intake of multiple vectors in a highly non-uniform fashion. Transfection of non-overlapping fluorescent proteins, which allowed us to follow the dynamics of the process, confirmed the tendency for parasites to take up multiple vectors from the early stages of transfection. This finding has important implications for how reverse genetics can be scaled in P. falciparum.
- organism: plant (other)
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Application of barcode sequencing to increase the throughput and complexity of Plasmodium falciparum genetic screening
Allan Muhwezi, Mehdi Ghorbal, … Julian C. Rayner·bioRxiv·Sep 5, 2024
- An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs
Nicolas M. B. Brancucci, Christin Gumpp, … Till Steffen Voss·Nature CommunicationsPeer-reviewed·Jul 25, 2025
- The translatome of quiescent Plasmodium falciparum gametocytes reveals parasite pyridoxal 5'-phosphate (PLP) biosynthesis is essential for efficient mosquito stage development
Eduardo Alves, Jack W. Houghton, … Michael J. Delves·PLoS PathogensPeer-reviewed·Sep 23, 2026
- Generation of Transgenic Human Malaria Parasites With Strong Fluorescence in the Transmission Stages
K. J. McLean, J. Straimer, … P. Sinnis·bioRxiv·Dec 18, 2018
- A high-throughput compound screen identifies multiple druggable targets in Plasmodium falciparum transmission stages
Leonie Seefeldt, Christin Gumpp, … Nicolas M. B. Brancucci·bioRxiv·Sep 13, 2026
- Transgenic pyrimethamine resistant Plasmodium berghei as a model for in vivo anti-DHFR drug testing
P. Koonyosying, N. Jupatanakul, … C. Uthaipibull·bioRxiv·Sep 30, 2020